
HKSEHealthcareMedical - Care Facilities
最新資料
HK$0.755
−HK$0.005 · -0.66%
Operating as an investment holding company, Human Health Holdings Limited delivers a comprehensive range of healthcare services across Hong Kong. Its primary care offerings encompass a wide array of services such as routine consultations, diagnostic testing, preventive health programs, minor medical interventions, immunizations, comprehensive physical examinations, health education, and occupational health guidance. Additionally, they provide Traditional Chinese Medicine, work injury assessments, telemedicine, COVID-19 specific services, community outreach, and various health-related products and solutions. The company extends its expertise to numerous specialized medical fields, including general surgery, orthopedics and traumatology, ophthalmology, otorhinolaryngology, pediatrics, obstetrics and gynecology, gastroenterology and hepatology, respiratory medicine, cardiology, pediatric surgery, dermatology and venereology, psychiatry, radiology, urology, nephrology, neurosurgery, anaesthesiology, and oncology. Complementing these are allied health services like physiotherapy, clinical psychology, medical aesthetics, nutritional counseling, health and wellness programs, endoscopy, and advanced medical diagnostics. Furthermore, a full spectrum of dental care is available, ranging from general dentistry, dental implants (including 3D guided surgery), crowns, bridges, and periodontal treatments, to prosthodontics, oral surgery, orthodontics, and endodontics. Cosmetic options like teeth whitening, veneers, and laser dentistry are also provided, alongside advanced oral and maxillofacial surgery, CAD/CAM technology, panoramic radiography, and cone-beam CT scans. Beyond direct patient care, the company manages agreements for healthcare practitioners and offers essential medical imaging services. Established in 1997 and headquartered in Kowloon, Hong Kong, Human Health Holdings Limited maintained a network of 58 medical centers and 103 service points as of June 30, 2021. It operates as a subsidiary of Treasure Group Global Limited.
最新資料
HK$0.755
−HK$0.005 · -0.66%
盤中時間採用HKT。市場資料可能有所延遲。
Operating as an investment holding company, Human Health Holdings Limited delivers a comprehensive range of healthcare services across Hong Kong. Its primary care offerings encompass a wide array of services such as routine consultations, diagnostic testing, preventive health programs, minor medical interventions, immunizations, comprehensive physical examinations, health education, and occupational health guidance. Additionally, they provide Traditional Chinese Medicine, work injury assessments, telemedicine, COVID-19 specific services, community outreach, and various health-related products and solutions. The company extends its expertise to numerous specialized medical fields, including general surgery, orthopedics and traumatology, ophthalmology, otorhinolaryngology, pediatrics, obstetrics and gynecology, gastroenterology and hepatology, respiratory medicine, cardiology, pediatric surgery, dermatology and venereology, psychiatry, radiology, urology, nephrology, neurosurgery, anaesthesiology, and oncology. Complementing these are allied health services like physiotherapy, clinical psychology, medical aesthetics, nutritional counseling, health and wellness programs, endoscopy, and advanced medical diagnostics. Furthermore, a full spectrum of dental care is available, ranging from general dentistry, dental implants (including 3D guided surgery), crowns, bridges, and periodontal treatments, to prosthodontics, oral surgery, orthodontics, and endodontics. Cosmetic options like teeth whitening, veneers, and laser dentistry are also provided, alongside advanced oral and maxillofacial surgery, CAD/CAM technology, panoramic radiography, and cone-beam CT scans. Beyond direct patient care, the company manages agreements for healthcare practitioners and offers essential medical imaging services. Established in 1997 and headquartered in Kowloon, Hong Kong, Human Health Holdings Limited maintained a network of 58 medical centers and 103 service points as of June 30, 2021. It operates as a subsidiary of Treasure Group Global Limited.
日內區間
目前HK$0.755
52週區間
目前HK$0.755
盤中時間採用HKT。市場資料可能有所延遲。
Operating as an investment holding company, Human Health Holdings Limited delivers a comprehensive range of healthcare services across Hong Kong. Its primary care offerings encompass a wide array of services such as routine consultations, diagnostic testing, preventive health programs, minor medical interventions, immunizations, comprehensive physical examinations, health education, and occupational health guidance. Additionally, they provide Traditional Chinese Medicine, work injury assessments, telemedicine, COVID-19 specific services, community outreach, and various health-related products and solutions. The company extends its expertise to numerous specialized medical fields, including general surgery, orthopedics and traumatology, ophthalmology, otorhinolaryngology, pediatrics, obstetrics and gynecology, gastroenterology and hepatology, respiratory medicine, cardiology, pediatric surgery, dermatology and venereology, psychiatry, radiology, urology, nephrology, neurosurgery, anaesthesiology, and oncology. Complementing these are allied health services like physiotherapy, clinical psychology, medical aesthetics, nutritional counseling, health and wellness programs, endoscopy, and advanced medical diagnostics. Furthermore, a full spectrum of dental care is available, ranging from general dentistry, dental implants (including 3D guided surgery), crowns, bridges, and periodontal treatments, to prosthodontics, oral surgery, orthodontics, and endodontics. Cosmetic options like teeth whitening, veneers, and laser dentistry are also provided, alongside advanced oral and maxillofacial surgery, CAD/CAM technology, panoramic radiography, and cone-beam CT scans. Beyond direct patient care, the company manages agreements for healthcare practitioners and offers essential medical imaging services. Established in 1997 and headquartered in Kowloon, Hong Kong, Human Health Holdings Limited maintained a network of 58 medical centers and 103 service points as of June 30, 2021. It operates as a subsidiary of Treasure Group Global Limited.
日內區間
目前HK$0.755
52週區間
目前HK$0.755
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(HKD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 6.72億 HKD | 6.44億 HKD | 5.91億 HKD | 10.02億 HKD | 11.22億 HKD |
| 銷貨成本 | 3.6億 HKD | 3.48億 HKD | 3.21億 HKD | 4.09億 HKD | 4.62億 HKD |
| 毛利 | 3.11億 HKD | 2.97億 HKD | 2.7億 HKD | 5.93億 HKD | 6.6億 HKD |
| 銷售、一般及管理費用 | 2.05億 HKD | 1.97億 HKD | 1.84億 HKD | 2.11億 HKD | 1.68億 HKD |
| 營業費用 | 2.05億 HKD | 1.97億 HKD | 1.84億 HKD | 2.11億 HKD | 1.68億 HKD |
| 利息收入 | 790.1萬 HKD | 1270.2萬 HKD | 1715.2萬 HKD | 849.1萬 HKD | 19.9萬 HKD |
| 利息支出 | 649.9萬 HKD | 655萬 HKD | 822萬 HKD | 829.7萬 HKD | 293.4萬 HKD |
| 折舊和攤銷 | 6690.3萬 HKD | 6770.6萬 HKD | 6800.9萬 HKD | 7479萬 HKD | 6307.4萬 HKD |
| 營業利益 | 1.06億 HKD | 9910.6萬 HKD | 1794.3萬 HKD | 3.07億 HKD | 4.29億 HKD |
| 淨利 | 2712.7萬 HKD | 2633.6萬 HKD | 2418.9萬 HKD | 1.81億 HKD | 3.75億 HKD |
公司資料更新於 2026年10月17日。
近期已公布業績
近期已公布業績
年度分割調整後的每股現金分配。
HK$0.03
2025年(完整年度)-75.0% 自從 2021
HK$0.12
2,021
HK$0.30
2,022
HK$0.16
2,023
HK$0.028
2,024
HK$0.03
2,025
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息即將實施 | 2026年12月11日 | HK$0.031Annual | 2026年12月15日 | 2027年1月5日 |
股息 | 2025年12月15日 | HK$0.03Annual | 2025年12月17日 | 2026年1月5日 |
股息 | 2024年12月4日 | HK$0.028Annual | 2024年12月6日 | 2024年12月30日 |
股息 | 2023年12月11日 | HK$0.16Annual | 2023年12月12日 | 2023年12月29日 |
股息 | 2022年12月6日 | HK$0.30Annual | 2022年12月7日 | 2022年12月23日 |
股息 | 2021年12月7日 | HK$0.12Annual | 2021年12月8日 | 2021年12月28日 |
除息 2026年12月11日
HK$0.031
Annual
2026年12月15日登記 · 支付日 2027年1月5日
除息 2025年12月15日
HK$0.03
Annual
2025年12月17日登記 · 支付日 2026年1月5日
除息 2024年12月4日
HK$0.028
Annual
2024年12月6日登記 · 支付日 2024年12月30日
除息 2023年12月11日
HK$0.16
Annual
2023年12月12日登記 · 支付日 2023年12月29日
除息 2022年12月6日
HK$0.30
Annual
2022年12月7日登記 · 支付日 2022年12月23日
除息 2021年12月7日
HK$0.12
Annual
2021年12月8日登記 · 支付日 2021年12月28日
AI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。